Introduction

Free-living amoebae (FLA) from the genus Acanthamoeba are ubiquitously distributed in nature (Siddiqui and Khan 2012). This parasite can be isolated from virtually any natural or artificial environment including soil, dust, water, air, medical equipment, lens fluids, air-conditioning, and nasopharyngeal mucosa from healthy individuals (Clarke and Niederkorn 2006; Nagyová et al. 2010a; Siddiqui and Khan 2012; Khezri et al. 2016; Tawfeek et al. 2016; Król-Turmińska and Olender 2017; Lass et al. 2017; Wopereis et al. 2020). Acanthamoeba spp. are among the most prevalent protozoa worldwide and are considered amphizoic organisms due to their ability to live either as a free-living organism or as pathogenic and opportunistic protozoa. This behavior enables Acanthamoeba sp. to live in close contact with potential hosts, including humans, leading to severe infections (Oddo 2006; Visvesvara et al. 2007; Lanocha et al. 2009).

Furthermore, these protozoa can disseminate many different pathogens besides causing infections by themselves. Acanthamoeba sp. protozoa are known as “Trojan horses,”' acting as a host for a wide range of microorganisms including viruses, protists, and bacteria, and in that way, being a reservoir for maintaining and dispersing those endosymbionts in the environment (Greub and Raoult 2004; Berger et al. 2006; Siddiqui and Khan 2012).

When Acanthamoeba sp. defeats the host barriers and establishes infection, it can result in a clinical condition called granulomatous amebic encephalitis (GAE). GAE is an opportunistic, insidious, and chronic infection of the central nervous system, which presents high mortality despite low incidence (Visvesvara et al. 2007; Visvesvara and Schuster 2008; Diaz 2010). These FLA can also cause several highly destructive and disseminating infections concerning lungs, kidneys, liver, adrenal glands, heart, bones, and skin, affecting both immunocompromised and immunocompetent patients. However, the most common extracerebral infection caused by this amoeba is Acanthamoeba keratitis (AK) (Khan 2006; Ren and Wu 2010; Walochnik et al. 2015; Kot et al. 2018). Acanthamoeba keratitis is a painful and severe sight-threatening corneal disease that can even lead to blindness. Unlike GAE, AK can also occur in immunocompetent individuals due to poor lens care or following a corneal trauma (Visvesvara et al. 2007; Dart et al. 2009).

The symptoms and clinical findings of AK include severe pain, considerable lacrimation, photophobia, inflammation, corneal abrasion and opacification, blurred vision, foreign body sensation, edema, stromal infiltration, epithelial loss, ring ulcers, cataract, glaucoma, and even corneal perforation and vision loss if not adequately treated (Khan 2006; Castrillón and Orozco 2013; Lorenzo-Morales et al. 2015). The same symptoms can occur in bacterial, fungal, and viral keratitis, commonly leading to a misdiagnosis. AK usually progresses slower than those infections (Lorenzo-Morales et al. 2013). Furthermore, coinfections of Acanthamoeba spp. with fungi as Fusarium and Candida, or bacteria as Pseudomonas have already been reported (Sharma et al. 2013; Nunes et al. 2016; Buchele et al. 2018).

In recent years, the prevalence of AK has rapidly increased due to the rising recognition of this infection as an essential threat to human health. This swelling in the prevalence, in part, is due to the availability of modern diagnostic methods that allow differential diagnosis from other keratitis, added to the increasing number of contact lens (CL) users, which is the main risk factor for AK (Khan 2006; Patel and Hammersmith 2008; Dart et al. 2009).

The number of CL users grows worldwide every year, and the number of AK cases is increasing concomitantly (Maycock and Jayaswal 2016). About 90% of patients diagnosed with AK are CL wearers, with reported rates between 1 and 33 cases per million (Khan 2006; Visvesvara et al. 2007). Considering that amoeba can reach lens cases through the air or tap water, AK infections are often related to poor cleaning, overuse, swimming, or sleeping wearing CL (Shoff et al. 2008; Walochnik et al. 2015). However, it is important to note that even patients who regularly disinfect their lens with a multipurpose solution can still contract AK since it has been shown that some commercially available cleaning solutions are ineffective against the protozoan (Kilvington et al. 2004; Hammersmith 2006; Shoff et al. 2008; Walochnik et al. 2015). One explanation for this phenomenon is the biofilm formation following lens contamination. The formed biofilm can enhance Acanthamoeba lifetime on lens storage added to provide nutrients for the amoeba, playing an essential role in the pathology of AK (Khan 2006). On top of this, there are more predisposing factors for AK, even for non-users of lenses, which include previous mechanical corneal trauma associated with exposure to contaminated soil, water, or vegetation (Jiang et al. 2006; Wesolowska et al. 2006; Lorenzo-Morales et al. 2015).

AK is one of the most challenging corneal diseases to be diagnosed. It is often only considered after the failure of the first-line therapy for herpes simplex virus or bacterial/fungal keratitis. In addition, currently diagnosis methods are invasive, requiring stromal biopsy or corneal scrapes, for example. Moreover, the sooner the disease is diagnosed, the better is the prognosis (Dart et al. 2009; Page and Mathers 2013).

AK treatment is difficult and long-termed, becoming an extremely challenging problem since there are no approved drugs for this infection specifically. Indeed, multiple antibacterial, antifungal, and antiamoebic agents are used in combination to improve the outcome (Gokhale 2008; Wilhelmus et al. 2008; Juárez et al. 2018). The challenges in treatment happen due to different factors, including the wide range of virulence showed by Acanthamoeba spp. which makes it challenging to establish a correlation between in vivo and in vitro drug activity. Furthermore, the cystic forms of Acanthamoeba sp. are extremely resistant. Even after a clinical cure, the treatment must continue for a long period to prevent relapses of the infection resulting from the sporulation of the remaining cysts (Kumar and Lloyd 2002; Astorga et al. 2011). When oral or topical treatments have failed in severe infections, corneal transplantation is the last therapeutic option (Kitzmann et al. 2009; Nguyen et al. 2010; Lorenzo-Morales et al. 2015). Among the measures that can be used to prevent the infection, one of the most important is to educate lens users regarding the proper care of contact lenses and its cases, the importance of appropriate disinfecting solutions, no overnight use, and no showering or swimming wearing CL, in order to avoid the contact with contaminated water (Visvesvara et al. 2007).

The life cycle of Acanthamoeba spp. consists of two stages: an actively feeding and reproductive trophozoite, and a latent cyst stage with minimal metabolic activity (Siddiqui and Khan 2012; Lorenzo-Morales et al. 2015). Trophozoites of Acanthamoeba spp. exhibit prominent vacuoles and typical acanthopodia, which are fine and spine-like structures on their surface. Their size usually is around 12–35 µm in diameter, but it can vary significantly between isolates due to the many different genotypes and species (Khan 2006; Visvesvara et al. 2007; Costa et al. 2010). The encystment occurs due to unfavorable environmental conditions such as desiccation, changes in pH and temperature, increased osmolarity or hypo-osmolarity, and food deprivation. The trophozoite becomes a metabolically inactive cyst with a double wall, composed of an endocyst and ectocyst, both containing cellulose (Marciano-Cabral and Cabral 2003; Munguía 2005; Siddiqui et al. 2012; Costa et al. 2010; Martín-Pérez et al. 2017). The cyst form allows the organism to survive to extreme conditions, retaining its pathogenic properties for long periods in hostile environments. Altogether, that explains why AK treatment is difficult because Acanthamoeba encysts when the environment becomes unfavorable due to the medications. Both cysts and trophozoites can adhere to the surface, including soft or rigid CL and contact lens cases, allowing the parasite to invade the eye tissue (Khan and Tareen 2003; Marciano-Cabral and Cabral 2003; Siddiqui and Khan 2012).

In an attempt to organize the increasing number of isolates belonging to the Acanthamoeba genus, Pussard and Pons (1977) initially classified the species based on morphological features of the cysts. Then, according to the ectocyst and endocyst shape and size, Acanthamoeba spp. were divided into three different morphological groups (I–III). This methodology allowed to differentiate more than 24 species of Acanthamoeba (Khan 2006; Visvesvara et al. 2007; Kłopocka et al. 2009; Fuerst et al. 2015; Derda et al. 2016). Most AK infections are caused by representatives of group II, though some isolates from group III have also been described as causative agents of the infection. Among the species of Acanthamoeba causing AK, the most prevalent are Acanthamoeba polyphaga and A. castellanii, although A. culbertsoni, A. rhysodes, A. griffini, A. quina, and A. lugdunensis have also been described as causing the infection (Clarke and Niederkorn 2006; Visvesvara 2010; Lorenzo-Morales et al. 2015).

Nevertheless, the classification based on morphologic criteria is considered ambiguous and unreliable currently. Species morphology might change depending on culture media conditions, resulting in variations in cyst morphology, an important feature for species identification. Furthermore, several studies have shown disagreements in the morphology of cysts from the same isolates, which implicates that morphological identification, alone, should not be used for species identification, requiring the use of molecular approaches (Khan 2006; Castrillón and Orozco 2013). Currently, molecular classification methods have been generated, generally classifying isolates based on the nuclear small subunit 18S ribosomal RNA whole gene sequence (Rns). This approach allows the differentiation of Acanthamoeba spp. into 22 genotypes (T1–T22) and encompasses all the Acanthamoeba isolates found so far (Corsaro et al. 2015; Fuerst et al. 2015; Corsaro et al. 2017; Taher et al. 2018).

Molecular techniques, especially the ones using ribosomal RNA (rRNA) amplification of the Rns amplicon ASA.S1 of 18S rRNA, are increasingly being used for rapid and helpful detection of Acanthamoeba. This fragment encodes the DF3 region, and the obtained sequences are compared with the Acanthamoeba reference strain sequence database. Because a reliable result is necessary, a similarity higher than 95% between isolates and reference sequences is recommended due to the high similarity between genotypes (Visvesvara et al. 2007; Lorenzo-Morales et al. 2015).

Several studies worldwide suggest that the predominant genotype in both keratitis and non-keratitis samples is the T4 genotype. Meanwhile, in a lower frequency, T2, T3, T5, T6, T8, T9, T11, T13, and T15 genotypes have also been isolated from patients with AK. Indeed, most of the genotypes known to date have been reported in human infection at least once. However, to the best of our knowledge, there is no study comprising global cases altogether. Instead, studies were limited to regional focus (Khan et al. 2002; Maghsood et al. 2005; Iovieno et al. 2010; Booton et al. 2009; Risler et al. 2013; Walochnik et al. 2014; Niyyati and Rezaeian 2015).

This systematic review proposes to assess the distribution of Acanthamoeba sp. genotypes in keratitis cases around the world. Here, we compare the frequency of AK among different geographic regions, considering the kind of sample collection and the identification method used.

Materials and methods

This systematic review was conducted by searching for articles in the English language on PubMed, Science Direct, Scielo, and Google Scholar databases. No restrictions were placed on studies’ dates, and the search returned journal articles from 2002 to 2020. The keywords used and combined in our search strategy were “Acanthamoeba,” “keratitis,” and “genotype.” All studies that assessed Acanthamoeba sp. genotypes from keratitis patients’ samples all around the world were included in this review. Studies in which samples were other than from keratitis patients, or were from contact lens apparatus, were excluded. Articles that did not specify the country where the samples were collected, or the genotype were also excluded.

All required data, such as the number of cases, type of sample collected, genotype, molecular biology method employed, primers used, pairwise sequence identities, species of Acanthamoeba, country of collection, and the year of the study, were extracted from each of the eligible articles and entered into Microsoft Excel software. It is important to note that all data presented in our research strictly reflect those reported by the original articles.

Results

A total of 2934 articles were addressed based on four databases: PubMed, Science Direct, Scielo, and Google Scholar. From those articles, 65 articles were used in the current study, as they met the previously selected inclusion criteria.

Our study collected data on the number of published articles containing cases of human keratitis caused by Acanthamoeba spp., the respective genotypes, and the year of publication. The number of publications per year can be seen in Fig. 1, where it is also pointed the first publication occurred in 2002 (Booton et al. 2002).

Fig. 1
figure 1

Publications per year of Acanthamoeba keratitis, indicating the genotype of the isolate and year of publication

Regarding the sample collected in each study, we can note a wide diverse type. Corneal scrapes were undoubtedly the most collected samples. However, most authors used more than one method for sampling in their studies. Usually, authors associate corneal scrapings with corneal biopsies, contact lenses, corneal swabs, and contact lens apparatus (lens maintenance solution, lens case). These associations can be seen in detail in Table 1.

Table 1 Details of the collected samples in each study with their respective references

In addition, only one study used unconventional samples, such as corneal button (Zhao et al. 2010) and amniotic membrane, a graft used to treat corneal epithelial defects (Sharifi et al. 2010). Some studies did not specify what kind of sample was collected, using only terms such as “symptomatic keratitis human patients” or “corneal samples.”

In terms of molecular approaches, we can notice that many studies used the conventional PCR technique to detect and identify Acanthamoeba isolates. This technique was used in combination with other molecular methods for quantification or phylogenetic analysis (Ghamilouie et al. 2014b; Antonelli et al. 2018; Orosz et al. 2018). The most widely used set of primers in the studies was JDP1 and JDP2, being present in 15 studies. These primers allow the amplification of the Rns amplicon ASA.S1 from 18S rRNA, which encodes the highly variable DF3 region.

For a reliable genotyping of Acanthamoeba isolates, amplification and sequencing of the target gene are necessary. Regarding the similarity amidst the genotypes belonging to the database, most of the articles showed data with similarity > 95%. However, there were found articles that did not bring this information in their results.

In the returned studies, genotyped AK cases were found in 4 continents: Asia, America, Europe, and Africa. Seven in Asia and America, 11 in Europe, and two in Africa, a total of 27 countries around the world. In addition, two of the studies did not specify the country where the samples were collected. Regardless, these studies were included in the systematic review since it was possible to know the continent to which they belonged, “North America,” and “Southern Africa.” No studies from the Oceania continent have been found so far.

A total of 675 cases of amoebic keratitis caused by Acanthamoeba spp. were found to be genotyped worldwide. From those cases, 253 were from Asia, 150 from America, 233 from Europe, and 40 from Africa. The total number of cases per genotype in each continent can be seen in Fig. 2. In this same figure, we can see that the T4 genotype was the most prevalent, and Asia was the continent with more cases of this genotype.

Fig. 2
figure 2

Relation between AK cases with the continents and genotypes returned. The number of cases of each genotype can be seen in parentheses

In Fig. 3, it is evident that the T4 genotype is the most prevalent worldwide, corresponding to 580 of the total 675 cases. The frequencies of the other genotypes were T3 (40), T15 (15), T11 (14), T5 (9), T2 (6), T12 (3), T7 (2), T8 (2), T10 (2), T9 (1), and T13 (1). When it comes to percentages, the prevalence of each genotype was: T4 (85.92%), T3 (5.92%), T15 (2.22%), T11 (2.07%), T5 (1.33%), T2 (0.88%), T12 (0.44%), T7 (0.29%), T8 (0.29%), T10 (0.29%), T9 (0.15%), and T13 (0.15%). In addition, it is important to note that in the cases described in this systematic review, the genotypes T1, T6, T14, T16, T17, T18, T19, T20, T21, and T22 were not found causing AK.

Fig. 3
figure 3

Worldwide cases of Acanthamoeba keratitis and their respective genotypes

Table 2 shows, with more details, the number of cases for each genotype among countries, along with the respective references.

Table 2 Returned genotypes by country where the sample comes from. The number of cases for each genotype can be found in parentheses

This systematic review showed that the T4 genotype, in addition to being responsible for the largest number of cases worldwide, also contains the larger number of Acanthamoeba species. In addition, it can be seen in Table 3 that the same species is related to different genotypes; for example, both A. castellani and A. palestinensis belong to genotype T4 and T2, A. culbertsoni belongs to genotype T4 and T10, and A. hatchetti belongs to genotype T4, T6, and T11. However, it is important to note that most of the articles do not have the identification of Acanthamoeba species.

Table 3 Acanthamoeba species related to each genotype and their respective references

Discussion

As a result of its ubiquity, the cosmopolitan Acanthamoeba protozoan poses a risk to human health due to its ability to infect the host and survive in the environment. Studies are still needed to clarify the pathogenicity of AK and other infections caused by this free-living amoeba, which can help enhance the search for therapeutic targets (Ledee et al. 2009).

Our study shows that in the last 20 years there has been a gradual increase in the number of studies genotyping Acanthamoeba isolates causing keratitis, especially in the last decade. Unfortunately, the pandemic of Sars-Cov-2 caused the number of publications to decrease to a similar number as 20 years ago, which is certainly an exception to the upward trend. Several factors are related to the increase in the number of AK cases worldwide every year, such as the widespread use of contact lenses for vision correction or cosmetic purposes together with better diagnostics, therefore becoming classified as an emerging disease (Panjwan 2010; Astorga et al. 2011). However, we have reasons to believe that this number is still underreported and, in addition, not all diagnosed cases are genotyped. Although there are several genotyping studies in some countries, to the best of our knowledge, there is no study listing all AK cases, thus providing a comprehensive view of the frequency of AK genotypes worldwide.

Different sample collection methods have been shown to be effective for isolating Acanthamoeba spp. in keratitis. Among these methods, there are corneal scraping, corneal biopsies, and corneal smears, as well as collections of contact lenses and their accessories, like lens cases and cleaning solutions. However, we can note that a predominant part of the studies chose to use corneal scrapes and contact lenses from AK patients.

It is recommended that the detection of Acanthamoeba spp. in keratitis patients be performed by molecular tests, such as conventional PCR or real-time PCR, with the last being faster and more accurate than the first one (Visvesvara et al. 2007; Corsaro et al. 2015; Maycock and Jayaswal 2016). Furthermore, in one study, Sharma et al. (2004) used a real-time multiplex PCR assay to detect Acanthamoeba, a molecular method that proved to be reliable and with sufficient sensitivity to detect up to 5 picograms of Acanthamoeba DNA.

When analyzing all genotyped cases of AK, our study shows that there were 580 cases genotyped as T4, corresponding to 85.92% of the total number of cases reported worldwide. In addition, the T4 genotype was the most prevalent on all continents where AK was found, suggesting that even in different countries, isolates with this genotype may have similar pathogenic properties. It is known that an important initial step in the pathology of AK is the adherence to corneal epithelial cells, which is strongly related to the expression of mannose-binding protein by Acanthamoeba sp. In the T4 genotype, this mannose-binding protein appears to bind more firmly to the membrane surface of host cells, which makes this genotype more cytotoxic than the others, and eventually being responsible for a higher number of infections (Hurt et al. 2003; Garate et al. 2006; Ledee et al. 2009; Noorjahan 2010). Furthermore, the exposure to mannose leads to the liberation of a low molecular weight protease called MIP133, which can have a cytolytic effect on corneal epithelial cells (Hurt et al. 2003; Garate et al. 2006; Ledee et al. 2009; Noorjahan 2010). As a result, it is assumed that T4 is the most virulent genotype, having properties that enhance its transmissibility, given its greatest environmental distribution (Maghsood et al. 2005; Ledee et al. 2009). Therefore, the highest expression of mannose-binding protein in the T4 genotype could be an effective target for new therapeutic approaches that would serve as a treatment for the vast majority of cases of amoebic keratitis.

We can also note that the genotype distribution among the four continents is very similar. In addition to T4, our study shows that the second most prevalent genotype was T3. It was the second most prevalent genotype in three of the four continents. The exception occurred in Africa, where the T5 genotype was the second most prevalent. However, this difference is not significant since the T5 genotype has only one more case than T3 in that continent. The T3 genotype was present in 40 reported cases, followed by T15 with 15 cases, T11 with 14, and T5 with 9. Other genotypes were also reported causing keratitis, although less frequently, as T2 (6 cases), T12 (3 cases), T7, T8, and T10 (2 cases each). Furthermore, T9 and T13 genotypes also caused Acanthamoeba keratitis, with one case each. However, it is important to note that the diagnosis of AK is complex, and the larger part of diagnosed cases were not genotyped. Furthermore, it is evident in this study that there is a difference in the number of genotyped cases among the continents, with the African continent having the lowest number of cases and Asia the largest, likely on account of support resources available. Therefore, our study describes the genotypic distribution of cases reported so far worldwide.

According to the reported scientific literature, infections caused by non-T4 genotypes are more aggressive, and the outcomes are extremely unfavorable, although the T4 genotype is the most prevalent (Iovieno et al. 2010; Sharifi et al. 2010). Because of this, we believe that the ideal scenario would consist of genotyping all isolates, although we know that it is almost impossible in practice.

In addition, reports of resistance to multipurpose cleaning solutions have already been related to non-T4 genotypes, like T3 and T5 (Shoff et al. 2007). Although multipurpose cleaning solutions are composed of different molecules from the medicines used for AK treatments, it indicates that such genotypes are more resistant, which can be related to a poor response to medical therapy. Moreover, according to Arnalich-Montiel et al. (2014), non-T4 genotypes have longer delays to diagnosis when compared with T4 genotypes and greater need for surgical intervention, that is, worse clinical outcomes.

Our study makes clear that, though A. castellani and A. polyphaga are the species most frequent in the T4 genotype, other species can also belong to this genotype, such as A. culbertsoni, A. triangularis, A. rhysodes, A. royreba, A. quina, and A. hatchetti. In addition, A. castellani and A. palestinensis were also related to the T2 genotype, and the T3 genotype was only related to A. griffini. It is clear that the classification of Acanthamoeba into species and genotypes still needs to be improved to clearly understand this relation. Furthermore, we agree with a recent study from Corsaro et al. (2020), which states that the identification of Acanthamoeba should currently have a more transparent organization than the classification based only on morphology that once was appropriate. Still today, it is a cause of confusion, relating several species to the same genotype.

It is important to highlight that there is not yet any effective treatment that could be used in all cases of AK. Therefore, novel therapeutics are needed to eliminate both amoeba life forms: trophozoites and cysts. It is important to remember that cyst forms are very resistant and related to the recurrence of infection. Given the differences in the pathology, virulence, susceptibility to treatment, and clinical outcomes between genotypes, genotype isolates are a path to be taken to have a better correlation between in vitro and in vivo efficacies, resulting in more effective therapies and successful treatment in AK cases.

In summary, Acanthamoeba genotyping has great importance for taxonomic purposes, understanding the geographical distribution of species, and also for clinical and epidemiological studies to better clarify this infection’s pathology and clinical outcomes. The literature shows that non-T4 genotypes can lead to more severe symptoms and have poorer response to medical therapy than genotype T4 (Arnalich-Montiel et al. 2014), though more than 85% of Acanthamoeba keratitis cases have been linked with T4 genotype, which is why it is supposedly the most virulent. AK remains a challenging disease to diagnose and treat, and further studies should be conducted to elucidate what makes some genotypes more pathogenic than others. This information would also play a fundamental role in providing new reliable diagnosis methods and novel therapeutic strategies.